Crinetics Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRNX and other ETFs, options, and stocks.About CRNX
Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly.
CEOScott R. Struthers
CEOScott R. Struthers
Employees437
Employees437
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2008
Founded2008
Employees437
Employees437
CRNX Key Statistics
Market cap4.16B
Market cap4.16B
Price-Earnings ratio-10.74
Price-Earnings ratio-10.74
Dividend yield—
Dividend yield—
Average volume1.69M
Average volume1.69M
High today—
High today—
Low today—
Low today—
Open price$44.29
Open price$44.29
Volume0.00
Volume0.00
52 Week high$62.53
52 Week high$62.53
52 Week low$24.10
52 Week low$24.10
Analyst ratings
88%
of 17 ratingsBuy
88.2%
Hold
11.8%
Sell
0%
People also own
Based on the portfolios of people who own CRNX. This list is generated using Robinhood data, and it’s not a recommendation.